Parkinson's Disease Online
Powered by the Michael J. Fox Foundation
Welcome
Guest
|
Be a part of PD Online Research
E-mail address:
*
Password:
*
recover password
Search the site:
Latest Posts
PD Guide
Funding Opportunities
Resources
Members
Newsletters
News
Research Questions
Conference Reports
POTW
Post here!
Ann Graybiel, PhD
Job title:
Institute Professor
Organization:
Massachusetts Institute of Technology
Contributions:
Published Contributions:
ABSTRACT: Evaluation of the Striatum-enriched Genes CalDAG-GEF1 and CalDAG-GEF2 as Targets for the Treatment and Prevention of L-DOPA Induced Dyskinesia
response to:
PD Therapeutics 2009: Poster Abstracts
17 Sep 2009 04:13 PM EST
The most widely prescribed therapy for Parkinson’s disease is levodopa (L-DOPA), which allows patients to regain motor control. However, many patients develop adverse reactions to L-DOPA, ...